Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.

Article Details

Citation

Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.

Alzheimers Res Ther. 2021 May 10;13(1):98. doi: 10.1186/s13195-021-00838-z.

PubMed ID
33971962 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs